Decoy Therapeutics (DCOY) Free Cash Flow by Year
Decoy Therapeutics Inc. recorded an outflow of $5.4M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Decoy Therapeutics Inc. has filed alongside them.
Ticker history: SLRX became DCOY (Decoy Therapeutics Inc.) on . Earlier news and filings retain their original names and dates. View SLRX history.
Annual figures, oldest first. Point at a bar to read its period.
DCOY Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
DCOY Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Decoy Therapeutics Inc. financials
Frequently Asked Questions
Decoy Therapeutics Inc. recorded an outflow of $5.4M in free cash flow in fiscal year 2025.
Decoy Therapeutics Inc. (DCOY) reported an outflow of $4.5M in free cash flow in fiscal year 2024 and an outflow of $5.4M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 11 fiscal years this page covers, Decoy Therapeutics Inc. (DCOY) free cash flow went from -$21.0M in fiscal year 2015 to -$5.4M in fiscal year 2025.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Decoy Therapeutics Inc. (DCOY) reported on that line in every period on record.